Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 10301-10350 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05180474
GEN1047 for Solid Tumors - First in Human (FIH) Trial
PHASE1/PHASE2
Active, not recruiting
179 participants
Started: Dec 13, 2021 · Completed: Mar 26, 2026
4 conditions
1 sponsor
36 locations
NCT05116189
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65)
PHASE3
Active, not recruiting
643 participants
Started: Dec 13, 2021 · Completed: Oct 25, 2028
3 conditions
1 sponsor
187 locations
NCT05163028
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
PHASE1
Active, not recruiting
42 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2026
7 conditions
1 sponsor
12 locations
NCT05139836
A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting
N/A
Active, not recruiting
634 participants
Started: Dec 13, 2021 · Completed: Sep 30, 2027
1 condition
1 sponsor
125 locations
NCT06698913
Feasibility and Efficacy of Automated Lateral Decubitus Therapy in Hypoxemic Respiratory Failure
NA
Active, not recruiting
80 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT05022654
SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma.
PHASE2
Active, not recruiting
22 participants
Started: Dec 13, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
6 locations
NCT04246203
Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer
N/A
Active, not recruiting
200 participants
Started: Dec 12, 2021 · Completed: Dec 1, 2026
1 condition
2 sponsors
6 locations
NCT05229354
Dengue Controlled Human Infection Model in Dhaka, Bangladesh
PHASE2
Active, not recruiting
192 participants
Started: Dec 11, 2021 · Completed: Jul 31, 2025
1 condition
2 sponsors
1 location
NCT03996109
Living Green and Healthy for Teens
NA
Active, not recruiting
74 participants
Started: Dec 11, 2021 · Completed: Dec 31, 2025
2 conditions
5 sponsors
1 location
NCT06314685
Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 Years
PHASE3
Active, not recruiting
2,450 participants
Started: Dec 10, 2021 · Completed: Aug 30, 2024
1 condition
1 sponsor
1 location
NCT05080764
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
PHASE2
Active, not recruiting
126 participants
Started: Dec 10, 2021 · Completed: Nov 30, 2025
1 condition
1 sponsor
9 locations
NCT05673837
the Type ONe dIabetic Bone Collaboration Study
N/A
Active, not recruiting
148 participants
Started: Dec 10, 2021 · Completed: Apr 1, 2024
2 conditions
7 sponsors
1 location
NCT05118724
Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin
PHASE2
Active, not recruiting
80 participants
Started: Dec 10, 2021 · Completed: Apr 30, 2027
1 condition
3 sponsors
1 location
NCT04929002
Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases
N/A
Active, not recruiting
50 participants
Started: Dec 10, 2021 · Completed: Dec 31, 2028
3 conditions
2 sponsors
1 location
NCT05120830
NTLA-2002 in Adults With Hereditary Angioedema (HAE)
PHASE1/PHASE2
Active, not recruiting
37 participants
Started: Dec 10, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
9 locations
NCT04770480
Non-pharmacological Treatment for Pain After Spine Surgery
NA
Active, not recruiting
267 participants
Started: Dec 10, 2021 · Completed: Mar 30, 2026
5 conditions
7 sponsors
3 locations
NCT04999969
Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
PHASE2
Active, not recruiting
126 participants
Started: Dec 10, 2021 · Completed: Aug 29, 2025
1 condition
1 sponsor
34 locations
NCT05266105
A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients
PHASE1
Active, not recruiting
60 participants
Started: Dec 10, 2021 · Completed: Jul 31, 2025
1 condition
2 sponsors
8 locations
NCT05093634
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
PHASE3
Active, not recruiting
400 participants
Started: Dec 10, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
56 locations
NCT05000710
Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy
PHASE2
Active, not recruiting
29 participants
Started: Dec 9, 2021 · Completed: Dec 31, 2026
1 condition
4 sponsors
1 location
NCT05160233
Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care
NA
Active, not recruiting
13,000 participants
Started: Dec 9, 2021 · Completed: Sep 9, 2024
4 conditions
2 sponsors
1 location
NCT03291470
Study to Determine the Efficacy and Safety of TG-C in Subjects with Kellgren/Lawrence Grade 2 or 3 OA of the Knee
PHASE3
Active, not recruiting
531 participants
Started: Dec 9, 2021 · Completed: Mar 6, 2026
1 condition
1 sponsor
27 locations
NCT05013099
Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies
PHASE2
Active, not recruiting
70 participants
Started: Dec 9, 2021 · Completed: Jul 31, 2025
4 conditions
1 sponsor
16 locations
NCT05029414
EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke
NA
Active, not recruiting
543 participants
Started: Dec 9, 2021 · Completed: Jun 1, 2025
1 condition
8 sponsors
56 locations
NCT04934475
MInimal Residual Disease Adapted Strategy
PHASE3
Active, not recruiting
791 participants
Started: Dec 8, 2021 · Completed: Sep 30, 2028
1 condition
4 sponsors
73 locations
NCT04667663
CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
PHASE1
Active, not recruiting
16 participants
Started: Dec 8, 2021 · Completed: Apr 30, 2026
1 condition
3 sponsors
3 locations
NCT05417802
Surveying Patient's Interest in Robotic Rehabilitation Device
N/A
Active, not recruiting
88 participants
Started: Dec 8, 2021 · Completed: Dec 7, 2026
1 condition
1 sponsor
1 location
NCT04786028
A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM
PHASE2
Active, not recruiting
72 participants
Started: Dec 8, 2021 · Completed: Jun 30, 2027
1 condition
1 sponsor
7 locations
NCT05127941
Andexanet Alfa: Non-interventional Study in Stroke Units in Germany (DE)
N/A
Active, not recruiting
141 participants
Started: Dec 8, 2021 · Completed: Mar 31, 2025
1 condition
1 sponsor
2 locations
NCT04867681
Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia
NA
Active, not recruiting
40 participants
Started: Dec 8, 2021 · Completed: Apr 24, 2026
1 condition
1 sponsor
1 location
NCT04377932
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
PHASE1
Active, not recruiting
24 participants
Started: Dec 8, 2021 · Completed: Aug 26, 2040
6 conditions
2 sponsors
1 location
NCT05155605
PATHFINDER 2: a Multi-Cancer Early Detection Study
NA
Active, not recruiting
35,885 participants
Started: Dec 8, 2021 · Completed: Apr 30, 2028
2 conditions
1 sponsor
56 locations
NCT04817254
Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
PHASE2
Active, not recruiting
47 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05122754
Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection
PHASE4
Active, not recruiting
150 participants
Started: Dec 8, 2021 · Completed: Apr 28, 2024
1 condition
3 sponsors
3 locations
NCT05081479
A Study of N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for Lymphoma
PHASE1
Active, not recruiting
9 participants
Started: Dec 8, 2021 · Completed: Oct 21, 2025
1 condition
1 sponsor
7 locations
NCT05099276
Extended Postoperative Oral Tranexamic Acid in Knee Replacement
PHASE4
Active, not recruiting
46 participants
Started: Dec 7, 2021 · Completed: Jun 1, 2024
3 conditions
1 sponsor
1 location
NCT05181475
Long-term Efficacy and Safety Study of GV-971
PHASE4
Active, not recruiting
800 participants
Started: Dec 7, 2021 · Completed: Jun 30, 2025
1 condition
1 sponsor
40 locations
NCT06412211
A Clinical Feasibility Study of a Photoacoustic Finder
N/A
Active, not recruiting
129 participants
Started: Dec 7, 2021 · Completed: Sep 30, 2024
2 conditions
2 sponsors
1 location
NCT05002777
Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)
PHASE2
Active, not recruiting
22 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2029
1 condition
1 sponsor
27 locations
NCT03482986
Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C
NA
Active, not recruiting
44 participants
Started: Dec 7, 2021 · Completed: May 31, 2025
3 conditions
2 sponsors
1 location
NCT04976127
Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients
PHASE1
Active, not recruiting
22 participants
Started: Dec 7, 2021 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT04997902
Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
PHASE1/PHASE2
Active, not recruiting
40 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
11 locations
NCT04059640
PMCF Study of LiquiBand FIX8® OHMF Device
NA
Active, not recruiting
109 participants
Started: Dec 7, 2021 · Completed: Jul 31, 2026
1 condition
2 sponsors
3 locations
NCT05020457
SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC.
PHASE2
Active, not recruiting
69 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
6 locations
NCT05027425
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
PHASE2
Active, not recruiting
30 participants
Started: Dec 7, 2021 · Completed: Dec 7, 2030
3 conditions
1 sponsor
3 locations
NCT05622669
Understanding Patterns of Fatigue in Health and Disease
N/A
Active, not recruiting
40 participants
Started: Dec 7, 2021 · Completed: Mar 30, 2024
3 conditions
6 sponsors
1 location
NCT04826224
CAM Procedure With BMAC for Shoulder OA
PHASE1
Active, not recruiting
12 participants
Started: Dec 6, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05034497
Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
PHASE1
Active, not recruiting
18 participants
Started: Dec 6, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
6 locations
NCT04838717
Clinical Trial of Doxycycline VS BPG for Early Syphilis (SY-DOXY)
PHASE3
Active, not recruiting
200 participants
Started: Dec 6, 2021 · Completed: Aug 3, 2025
1 condition
1 sponsor
7 locations
NCT04597671
Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)
PHASE3
Active, not recruiting
170 participants
Started: Dec 6, 2021 · Completed: Dec 31, 2032
1 condition
1 sponsor
14 locations
Previous
1
More pages
204
205
206
207
208
209
210
More pages
431
Next